Alexander WS, Hilton DJ: The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response. Annu Rev Immunol. 2004, 22: 503-529. 10.1146/annurev.immunol.22.091003.090312.
Article
CAS
PubMed
Google Scholar
Ryo A, Suizu F, Yoshida Y, Perrem K, Liou YC, Wulf G, Rottapel R, Yamaoka S, Lu KP: Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. Mol Cell. 2003, 12 (6): 1413-1426. 10.1016/S1097-2765(03)00490-8.
Article
CAS
PubMed
Google Scholar
Liu E, Cote JF, Vuori K: Negative regulation of FAK signaling by SOCS proteins. Embo J. 2003, 22 (19): 5036-5046. 10.1093/emboj/cdg503.
Article
CAS
PubMed
PubMed Central
Google Scholar
De Sepulveda P, Okkenhaug K, Rose JL, Hawley RG, Dubreuil P, Rottapel R: Socs1 binds to multiple signalling proteins and suppresses steel factor-dependent proliferation. Embo J. 1999, 18 (4): 904-915. 10.1093/emboj/18.4.904.
Article
CAS
PubMed
PubMed Central
Google Scholar
Rui L, Yuan M, Frantz D, Shoelson S, White MF: SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J Biol Chem. 2002, 277 (44): 42394-42398. 10.1074/jbc.C200444200.
Article
CAS
PubMed
Google Scholar
De Sepulveda P, Ilangumaran S, Rottapel R: Suppressor of cytokine signaling-1 inhibits VAV function through protein degradation. J Biol Chem. 2000, 275 (19): 14005-14008. 10.1074/jbc.C000106200.
Article
CAS
PubMed
Google Scholar
Oshimo Y, Kuraoka K, Nakayama H, Kitadai Y, Yoshida K, Chayama K, Yasui W: Epigenetic inactivation of SOCS-1 by CpG island hypermethylation in human gastric carcinoma. Int J Cancer. 2004, 112 (6): 1003-1009. 10.1002/ijc.20521.
Article
CAS
PubMed
Google Scholar
Sutherland KD, Lindeman GJ, Choong DY, Wittlin S, Brentzell L, Phillips W, Campbell IG, Visvader JE: Differential hypermethylation of SOCS genes in ovarian and breast carcinomas. Oncogene. 2004, 23 (46): 7726-7733. 10.1038/sj.onc.1207787.
Article
CAS
PubMed
Google Scholar
Yoshikawa H, Matsubara K, Qian GS, Jackson P, Groopman JD, Manning JE, Harris CC, Herman JG: SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. Nat Genet. 2001, 28 (1): 29-35. 10.1038/88225.
CAS
PubMed
Google Scholar
Weber A, Hengge UR, Bardenheuer W, Tischoff I, Sommerer F, Markwarth A, Dietz A, Wittekind C, Tannapfel A: SOCS-3 is frequently methylated in head and neck squamous cell carcinoma and its precursor lesions and causes growth inhibition. Oncogene. 2005, 24 (44): 6699-6708. 10.1038/sj.onc.1208818.
Article
CAS
PubMed
Google Scholar
He B, You L, Uematsu K, Zang K, Xu Z, Lee AY, Costello JF, McCormick F, Jablons DM: SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer. Proc Natl Acad Sci U S A. 2003, 100 (24): 14133-14138. 10.1073/pnas.2232790100.
Article
CAS
PubMed
PubMed Central
Google Scholar
Watanabe D, Ezoe S, Fujimoto M, Kimura A, Saito Y, Nagai H, Tachibana I, Matsumura I, Tanaka T, Kanegane H, Miyawaki T, Emi M, Kanakura Y, Kawase I, Naka T, Kishimoto T: Suppressor of cytokine signalling-1 gene silencing in acute myeloid leukaemia and human haematopoietic cell lines. Br J Haematol. 2004, 126 (5): 726-735. 10.1111/j.1365-2141.2004.05107.x.
Article
CAS
PubMed
Google Scholar
Galm O, Yoshikawa H, Esteller M, Osieka R, Herman JG: SOCS-1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myeloma. Blood. 2003, 101 (7): 2784-2788. 10.1182/blood-2002-06-1735.
Article
CAS
PubMed
Google Scholar
Rottapel R, Ilangumaran S, Neale C, La Rose J, Ho JM, Nguyen MH, Barber D, Dubreuil P, de Sepulveda P: The tumor suppressor activity of SOCS-1. Oncogene. 2002, 21 (28): 4351-4362. 10.1038/sj.onc.1205537.
Article
CAS
PubMed
Google Scholar
Pollak MN, Schernhammer ES, Hankinson SE: Insulin-like growth factors and neoplasia. Nat Rev Cancer. 2004, 4 (7): 505-518. 10.1038/nrc1387.
Article
CAS
PubMed
Google Scholar
Wood TL, Richert MM, Stull MA, Allar MA: The insulin-like growth factors (IGFs) and IGF binding proteins in postnatal development of murine mammary glands. J Mammary Gland Biol Neoplasia. 2000, 5 (1): 31-42. 10.1023/A:1009511131541.
Article
CAS
PubMed
Google Scholar
Khandwala HM, McCutcheon IE, Flyvbjerg A, Friend KE: The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev. 2000, 21 (3): 215-244. 10.1210/er.21.3.215.
Article
CAS
PubMed
Google Scholar
Widschwendter A, Tonko-Geymayer S, Welte T, Daxenbichler G, Marth C, Doppler W: Prognostic significance of signal transducer and activator of transcription 1 activation in breast cancer. Clin Cancer Res. 2002, 8 (10): 3065-3074.
CAS
PubMed
Google Scholar
Marth C, Fiegl H, Zeimet AG, Muller-Holzner E, Deibl M, Doppler W, Daxenbichler G: Interferon-gamma expression is an independent prognostic factor in ovarian cancer. Am J Obstet Gynecol. 2004, 191 (5): 1598-1605. 10.1016/j.ajog.2004.05.007.
Article
CAS
PubMed
Google Scholar
Bieche I, Onody P, Laurendeau I, Olivi M, Vidaud D, Lidereau R, Vidaud M: Real-time reverse transcription-PCR assay for future management of ERBB2-based clinical applications. Clin Chem. 1999, 45 (8 Pt 1): 1148-1156.
CAS
PubMed
Google Scholar
Masuhara M, Sakamoto H, Matsumoto A, Suzuki R, Yasukawa H, Mitsui K, Wakioka T, Tanimura S, Sasaki A, Misawa H, Yokouchi M, Ohtsubo M, Yoshimura A: Cloning and characterization of novel CIS family genes. Biochem Biophys Res Commun. 1997, 239 (2): 439-446. 10.1006/bbrc.1997.7484.
Article
CAS
PubMed
Google Scholar
Wolf D, Wolf AM, Rumpold H, Fiegl H, Zeimet AG, Muller-Holzner E, Deibl M, Gastl G, Gunsilius E, Marth C: The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer. Clin Cancer Res. 2005, 11 (23): 8326-8331. 10.1158/1078-0432.CCR-05-1244.
Article
CAS
PubMed
Google Scholar
Farabegoli F, Ceccarelli C, Santini D, Taffurelli M: Suppressor of cytokine signalling 2 (SOCS-2) expression in breast carcinoma. J Clin Pathol. 2005, 58 (10): 1046-1050. 10.1136/jcp.2004.024919.
Article
CAS
PubMed
PubMed Central
Google Scholar
Teglund S, McKay C, Schuetz E, van Deursen JM, Stravopodis D, Wang D, Brown M, Bodner S, Grosveld G, Ihle JN: Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell. 1998, 93 (5): 841-850. 10.1016/S0092-8674(00)81444-0.
Article
CAS
PubMed
Google Scholar
Shin A, Ren Z, Shu XO, Cai Q, Gao YT, Zheng W: Expression patterns of insulin-like growth factor 1 (IGF-I) and its receptor in mammary tissues and their associations with breast cancer survival. Breast Cancer Res Treat. 2006
Google Scholar
Rosen PP, Saigo PE, Braun DW, Weathers E, Kinne DW: Prognosis in stage II (T1N1M0) breast cancer. Ann Surg. 1981, 194 (5): 576-584.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hendriksen PJ, Dits NF, Kokame K, Veldhoven A, van Weerden WM, Bangma CH, Trapman J, Jenster G: Evolution of the androgen receptor pathway during progression of prostate cancer. Cancer Res. 2006, 66 (10): 5012-5020. 10.1158/0008-5472.CAN-05-3082.
Article
CAS
PubMed
Google Scholar
Wikman H, Kettunen E, Seppanen JK, Karjalainen A, Hollmen J, Anttila S, Knuutila S: Identification of differentially expressed genes in pulmonary adenocarcinoma by using cDNA array. Oncogene. 2002, 21 (37): 5804-5813. 10.1038/sj.onc.1205726.
Article
CAS
PubMed
Google Scholar
Raccurt M, Tam SP, Lau P, Mertani HC, Lambert A, Garcia-Caballero T, Li H, Brown RJ, McGuckin MA, Morel G, Waters MJ: Suppressor of cytokine signalling gene expression is elevated in breast carcinoma. Br J Cancer. 2003, 89 (3): 524-532. 10.1038/sj.bjc.6601115.
Article
CAS
PubMed
PubMed Central
Google Scholar
Metcalf D, Greenhalgh CJ, Viney E, Willson TA, Starr R, Nicola NA, Hilton DJ, Alexander WS: Gigantism in mice lacking suppressor of cytokine signalling-2. Nature. 2000, 405 (6790): 1069-1073. 10.1038/35016611.
Article
CAS
PubMed
Google Scholar
Greenhalgh CJ, Rico-Bautista E, Lorentzon M, Thaus AL, Morgan PO, Willson TA, Zervoudakis P, Metcalf D, Street I, Nicola NA, Nash AD, Fabri LJ, Norstedt G, Ohlsson C, Flores-Morales A, Alexander WS, Hilton DJ: SOCS2 negatively regulates growth hormone action in vitro and in vivo. J Clin Invest. 2005, 115 (2): 397-406. 10.1172/JCI200522710.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hadsell DL, Murphy KL, Bonnette SG, Reece N, Laucirica R, Rosen JM: Cooperative interaction between mutant p53 and des(1-3)IGF-I accelerates mammary tumorigenesis. Oncogene. 2000, 19 (7): 889-898. 10.1038/sj.onc.1203386.
Article
CAS
PubMed
Google Scholar
Wu Y, Cui K, Miyoshi K, Hennighausen L, Green JE, Setser J, LeRoith D, Yakar S: Reduced circulating insulin-like growth factor I levels delay the onset of chemically and genetically induced mammary tumors. Cancer Res. 2003, 63 (15): 4384-4388.
CAS
PubMed
Google Scholar
Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, Rosner B, Speizer FE, Pollak M: Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet. 1998, 351 (9113): 1393-1396. 10.1016/S0140-6736(97)10384-1.
Article
CAS
PubMed
Google Scholar
Voskuil DW, Bosma A, Vrieling A, Rookus MA, van 't Veer LJ: Insulin-like growth factor (IGF)-system mRNA quantities in normal and tumor breast tissue of women with sporadic and familial breast cancer risk. Breast Cancer Res Treat. 2004, 84 (3): 225-233. 10.1023/B:BREA.0000019954.59130.d3.
Article
CAS
PubMed
Google Scholar
Yee D, Paik S, Lebovic GS, Marcus RR, Favoni RE, Cullen KJ, Lippman ME, Rosen N: Analysis of insulin-like growth factor I gene expression in malignancy: evidence for a paracrine role in human breast cancer. Mol Endocrinol. 1989, 3 (3): 509-517.
Article
CAS
PubMed
Google Scholar
van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, Parrish M, Atsma D, Witteveen A, Glas A, Delahaye L, van der Velde T, Bartelink H, Rodenhuis S, Rutgers ET, Friend SH, Bernards R: A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med. 2002, 347 (25): 1999-2009. 10.1056/NEJMoa021967.
Article
CAS
PubMed
Google Scholar
Davey HW, Xie T, McLachlan MJ, Wilkins RJ, Waxman DJ, Grattan DR: STAT5b is required for GH-induced liver IGF-I gene expression. Endocrinology. 2001, 142 (9): 3836-3841. 10.1210/en.142.9.3836.
Article
CAS
PubMed
Google Scholar
Greenhalgh CJ, Bertolino P, Asa SL, Metcalf D, Corbin JE, Adams TE, Davey HW, Nicola NA, Hilton DJ, Alexander WS: Growth enhancement in suppressor of cytokine signaling 2 (SOCS-2)-deficient mice is dependent on signal transducer and activator of transcription 5b (STAT5b). Mol Endocrinol. 2002, 16 (6): 1394-1406. 10.1210/me.16.6.1394.
Article
CAS
PubMed
Google Scholar
Liu X, Robinson GW, Wagner KU, Garrett L, Wynshaw-Boris A, Hennighausen L: Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev. 1997, 11 (2): 179-186. 10.1101/gad.11.2.179.
Article
CAS
PubMed
Google Scholar
Cui Y, Riedlinger G, Miyoshi K, Tang W, Li C, Deng CX, Robinson GW, Hennighausen L: Inactivation of Stat5 in mouse mammary epithelium during pregnancy reveals distinct functions in cell proliferation, survival, and differentiation. Mol Cell Biol. 2004, 24 (18): 8037-8047. 10.1128/MCB.24.18.8037-8047.2004.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bratthauer GL, Strauss BL, Tavassoli FA: STAT 5a expression in various lesions of the breast. Virchows Arch. 2006, 448 (2): 165-171. 10.1007/s00428-005-0056-6.
Article
CAS
PubMed
Google Scholar
Nevalainen MT, Xie J, Torhorst J, Bubendorf L, Haas P, Kononen J, Sauter G, Rui H: Signal transducer and activator of transcription-5 activation and breast cancer prognosis. J Clin Oncol. 2004, 22 (11): 2053-2060. 10.1200/JCO.2004.11.046.
Article
CAS
PubMed
Google Scholar
Yamashita H, Nishio M, Ando Y, Zhang Z, Hamaguchi M, Mita K, Kobayashi S, Fujii Y, Iwase H: Stat5 expression predicts response to endocrine therapy and improves survival in estrogen receptor-positive breast cancer. Endocr Relat Cancer. 2006, 13 (3): 885-893. 10.1677/erc.1.01095.
Article
CAS
PubMed
Google Scholar
Favre H, Benhamou A, Finidori J, Kelly PA, Edery M: Dual effects of suppressor of cytokine signaling (SOCS-2) on growth hormone signal transduction. FEBS Lett. 1999, 453 (1-2): 63-66. 10.1016/S0014-5793(99)00681-X.
Article
CAS
PubMed
Google Scholar
Greenhalgh CJ, Metcalf D, Thaus AL, Corbin JE, Uren R, Morgan PO, Fabri LJ, Zhang JG, Martin HM, Willson TA, Billestrup N, Nicola NA, Baca M, Alexander WS, Hilton DJ: Biological evidence that SOCS-2 can act either as an enhancer or suppressor of growth hormone signaling. J Biol Chem. 2002, 277 (43): 40181-40184. 10.1074/jbc.C200450200.
Article
CAS
PubMed
Google Scholar
Michaylira CZ, Ramocki NM, Simmons JG, Tanner CK, McNaughton KK, Woosley JT, Greenhalgh CJ, Lund PK: Haplotype insufficiency for suppressor of cytokine signaling-2 enhances intestinal growth and promotes polyp formation in growth hormone-transgenic mice. Endocrinology. 2006, 147 (4): 1632-1641. 10.1210/en.2005-1241.
Article
CAS
PubMed
Google Scholar
Leung KC, Doyle N, Ballesteros M, Sjogren K, Watts CK, Low TH, Leong GM, Ross RJ, Ho KK: Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2. Proc Natl Acad Sci U S A. 2003, 100 (3): 1016-1021. 10.1073/pnas.0337600100.
Article
CAS
PubMed
PubMed Central
Google Scholar
Leong GM, Moverare S, Brce J, Doyle N, Sjogren K, Dahlman-Wright K, Gustafsson JA, Ho KK, Ohlsson C, Leung KC: Estrogen up-regulates hepatic expression of suppressors of cytokine signaling-2 and -3 in vivo and in vitro. Endocrinology. 2004, 145 (12): 5525-5531. 10.1210/en.2004-0061.
Article
CAS
PubMed
Google Scholar